Idiopathic pulmonary fibrosis trials in Argentina

In Argentina 6 Also abroad 111

6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Where
Buenos Aires, Córdoba, Mar del Plata, Quilmes, Rosario, San Luis, San Miguel de Tucumán, Santa Fe
Age
40 years and over
People
324 worldwide
Run by
Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00
Phase 2Taking people
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Where
Buenos Aires, San Miguel de Tucumán
Age
18 years and over
People
340 worldwide
Run by
Avalyn Pharma Inc.
See details and how to joinNCT06951217
Phase 3Not yet taking people in Argentina
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
Where
Buenos Aires, CABA, Córdoba, Florida, Vicente López, Godoy Cruz, Mar del Plata, Mendoza, Quilmes, Rosario, San Juan Bautista, San Miguel de Tucumán, Santa Fe
Age
18 years and over
People
2,380 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00
Phase 2Taking people
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Where
Alberdi, Buenos Aires, Ciudad de Buenos Aires, Florida, Rosario, San Fernando
Age
40 years and over
People
359 worldwide
Run by
AstraZeneca
See details and how to joinNCT07652658
Phase 3Enrolling by invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Where
Buenos Aires, Ciudad Autónoma de Buenos Aires, Córdoba, Mar del Plata, Mendoza, Río Cuarto, Rosario, San Miguel de Tucumán
Age
40 years and over
People
1,850 worldwide
Run by
United Therapeutics
See details and how to joinNCT04905693
Phase 3Taking people
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Where
Buenos Aires, Córdoba, Mar del Plata, Río Cuarto, Rosario, San Miguel de Tucumán
Age
18 years and over
People
698 worldwide
Run by
United Therapeutics
See details and how to joinNCT05943535 · EU 2023-504904-26-00